Cyrela Brazil Realty SA Empreendimentos e Participacoes
BOVESPA:CYRE3
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
17.1
25.49
|
| Price Target |
|
We'll email you a reminder when the closing price reaches BRL.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Cyrela Brazil Realty SA Empreendimentos e Participacoes
Other Assets
Cyrela Brazil Realty SA Empreendimentos e Participacoes
Other Assets Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
C
|
Cyrela Brazil Realty SA Empreendimentos e Participacoes
BOVESPA:CYRE3
|
Other Assets
R$165.7m
|
CAGR 3-Years
110%
|
CAGR 5-Years
115%
|
CAGR 10-Years
26%
|
|
|
Cury Construtora e Incorporadora SA
BOVESPA:CURY3
|
Other Assets
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
EZTEC Empreendimentos e Participacoes SA
BOVESPA:EZTC3
|
Other Assets
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
D
|
Direcional Engenharia SA
BOVESPA:DIRR3
|
Other Assets
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
MRV Engenharia e Participacoes SA
BOVESPA:MRVE3
|
Other Assets
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Plano & Plano Desenvolvimento Imobiliario SA
BOVESPA:PLPL3
|
Other Assets
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Cyrela Brazil Realty SA Empreendimentos e Participacoes
Glance View
In the vibrant tapestry of Brazil's urban landscape, Cyrela Brazil Realty SA Empreendimentos e Participacoes stands as a cornerstone of real estate innovation and prowess. Founded in 1962 by Elie Horn, Cyrela has blossomed into one of the largest residential real estate companies in Brazil. Its portfolio spans high-end residences to versatile commercial properties, capturing the dynamic essence of Brazilian metropolitan life. The company is headquartered in São Paulo, the beating heart of Brazil's economic activity, and it navigates the complexities of property development with an adept understanding of local market demands, regulatory intricacies, and the unique cultural nuances of each area it serves. Cyrela's revenue streams are strategically intertwined with key phases of property development and sales. The company primarily generates income through the sale of residential units, which are meticulously designed to meet the varied tastes and needs of its clientele. Additionally, Cyrela embraces joint ventures and partnerships, sharing risks and expanding its reach across different markets. This approach not only diversifies its financial exposure but also solidifies its reputation as a collaborative force in Brazil's real estate sector. By leveraging its expertise in construction efficiency, customer service, and market adaptation, Cyrela continues to sculpt the skylines of Brazil, one innovative project at a time. Through its commitment to quality and strategic flexibility, Cyrela not only builds homes but also lays the foundation for communities, contributing to the fabric of urban life in Brazil.
See Also
What is Cyrela Brazil Realty SA Empreendimentos e Participacoes's Other Assets?
Other Assets
165.7m
BRL
Based on the financial report for Sep 30, 2024, Cyrela Brazil Realty SA Empreendimentos e Participacoes's Other Assets amounts to 165.7m BRL.
What is Cyrela Brazil Realty SA Empreendimentos e Participacoes's Other Assets growth rate?
Other Assets CAGR 10Y
26%
Over the last year, the Other Assets growth was -10%. The average annual Other Assets growth rates for Cyrela Brazil Realty SA Empreendimentos e Participacoes have been 110% over the past three years , 115% over the past five years , and 26% over the past ten years .
You don't have any saved screeners yet
